Search
-
Searchresult: Team
Head of Division Managment Assistant Scientists Technical Assistance
-
Searchresult: Cell Therapy
Our Research Teamleader: Lukas Bunse, MD, PhD The Cell Therapy Team within the Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology develops preclinical immune…
-
Searchresult: Immune Microenvironment
Our Research The D170 Microenvironment Team focuses on identification of immunotherapeutic targets within the central nervous system microenvironment with the goal to enhance the reactivity of the…
-
Searchresult: Immunotherapy Brain Tumor Models
Our Research Teamleader: Theresa Bunse, PhD Despite a strict control of immune processes in the central nervous system (CNS), CNS immunity is off balance during autoimmune diseases and in CNS…
-
Searchresult: Immune monitoring and TCR discovery
Our Research The immune monitoring unit is located at the NCT and analyzes samples from cancer patients of various entities enrolled in clinical trials. We are specialized in monitoring antigen…
-
Searchresult: Radiotracer Unit
The Radiotracer group is currently working on the following topics: Establishment of GMP compliant production and quality control The working group has a long-standing expertise in the GMP…
-
Searchresult: Radiopharmaceuticals
The "Radiopharmaceuticals" working group of the "Radiopharmaceuticals and Preclinical Studies" sevice unit is focusing on the development and optimization of radiopharmaceuticals for preclinical…
-
Searchresult: Cyclotron and Target Development Unit
Radioisotope production is an interdisciplinary field comprising the amalgam of science and engineering. The 'Cyclotron and Target Development' group at DKFZ utilizes this blend to focus on…
-
Searchresult: Radiopharmaceuticals and Preclinical Studies
Morszeck Preclinical Trial Unit (PCTU) Radiotracer Unit Radiopharmaceuticals Cyclotron and Target Development Unit. In addition to imaging and irradiation design/irradiation for preclinical…
-
Searchresult: Multiple myeloma: When cancer cells break out of the bone marrow, a dangerous diversity arisesMultiple myeloma: When cancer cells break out of the bone marrow, a dangerous diversity arises Date: 07.02.2025 Press release content type: Press release
A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ) and the Berlin Institute of Health at Charité (BIH) has gained significant insights into the progression…
Press release